(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.92%) $83.08
(-1.16%) $1.619
(-0.29%) $2 340.50
(0.02%) $27.54
(0.57%) $927.40
(-0.16%) $0.933
(-0.18%) $11.00
(-0.24%) $0.798
(0.00%) $92.17
3 days till quarter result
(bmo 2024-05-02)
Expected move: +/- 6.61%
@ $80.96
発行日: 26 4月 2024 @ 04:38
リターン: 0.01%
前回のシグナル: 4月 26 - 01:49
前回のシグナル:
リターン: 0.63 %
Live Chart Being Loaded With Signals
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally...
Stats | |
---|---|
本日の出来高 | 435 170 |
平均出来高 | 831 755 |
時価総額 | 11.15B |
EPS | $0 ( 2024-02-13 ) |
次の収益日 | ( $0.460 ) 2024-05-02 |
Last Dividend | $0.0500 ( 2024-02-29 ) |
Next Dividend | $0 ( N/A ) |
P/E | 27.92 |
ATR14 | $1.870 (2.31%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-16 | Laukien Frank H | Sell | 1 404 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Buy | 10 000 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Buy | 5 000 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Sell | 13 772 | Common Stock |
2024-03-04 | Requardt Hermann Fritz | Sell | 1 228 | Common Stock |
INSIDER POWER |
---|
-31.65 |
Last 100 transactions |
Buy: 483 678 | Sell: 1 126 200 |
ボリューム 相関
Bruker Corp 相関
10 最も負の相関 | |
---|---|
BMRA | -0.919 |
BWB | -0.911 |
HRMY | -0.91 |
SLN | -0.906 |
INCR | -0.903 |
SFST | -0.903 |
EQBK | -0.902 |
PEAR | -0.902 |
PMVP | -0.902 |
CSSEP | -0.901 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Bruker Corp 相関 - 通貨/商品
Bruker Corp 財務諸表
Annual | 2023 |
収益: | $2.96B |
総利益: | $1.52B (51.17 %) |
EPS: | $2.92 |
FY | 2023 |
収益: | $2.96B |
総利益: | $1.52B (51.17 %) |
EPS: | $2.92 |
FY | 2022 |
収益: | $2.53B |
総利益: | $1.31B (51.59 %) |
EPS: | $2.00 |
FY | 2022 |
収益: | $2.53B |
総利益: | $1.31B (51.59 %) |
EPS: | $2.00 |
Financial Reports:
No articles found.
Bruker Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0.0500 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0400 | 2016-03-02 |
Last Dividend | $0.0500 | 2024-02-29 |
Next Dividend | $0 | N/A |
Payout Date | 2024-03-15 | |
Next Payout Date | N/A | |
# dividends | 33 | -- |
Total Paid Out | $1.410 | -- |
Avg. Dividend % Per Year | 0.21% | -- |
Score | 4.59 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.12 | |
Div. Directional Score | 8.92 | -- |
Year | Amount | Yield |
---|---|---|
2016 | $0.160 | 0.68% |
2017 | $0.160 | 0.74% |
2018 | $0.160 | 0.46% |
2019 | $0.160 | 0.55% |
2020 | $0.160 | 0.31% |
2021 | $0.160 | 0.30% |
2022 | $0.200 | 0.25% |
2023 | $0.200 | 0.29% |
2024 | $0.0500 | 0.07% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.144 | 1.500 | 7.12 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.101 | 1.200 | 6.65 | 7.98 | [0 - 0.3] |
returnOnEquityTTM | 0.338 | 1.500 | 7.35 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0688 | -1.000 | 9.31 | -9.31 | [0 - 1] |
currentRatioTTM | 1.800 | 0.800 | 6.00 | 4.80 | [1 - 3] |
quickRatioTTM | 0.933 | 0.800 | 9.22 | 7.37 | [0.8 - 2.5] |
cashRatioTTM | 0.406 | 1.500 | 8.85 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.303 | -1.500 | 4.94 | -7.42 | [0 - 0.6] |
interestCoverageTTM | -11.98 | 1.000 | -5.55 | -5.55 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.671 | 2.00 | 9.16 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.936 | -1.500 | 6.26 | -9.38 | [0 - 2.5] |
grossProfitMarginTTM | 0.510 | 1.000 | 4.84 | 4.84 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.149 | 1.000 | 9.02 | 9.02 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.272 | 1.000 | 9.60 | 9.60 | [0.2 - 2] |
assetTurnoverTTM | 0.698 | 0.800 | 8.68 | 6.95 | [0.5 - 2] |
Total Score | 11.71 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 27.58 | 1.000 | 7.32 | 0 | [1 - 100] |
returnOnEquityTTM | 0.338 | 2.50 | 8.30 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.671 | 2.00 | 9.44 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.247 | 1.500 | 3.82 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0688 | 1.500 | 9.31 | -9.31 | [0 - 1] |
pegRatioTTM | 0.361 | 1.500 | -0.929 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.118 | 1.000 | 9.55 | 0 | [0.1 - 0.5] |
Total Score | 6.12 |
Bruker Corp
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation has a collaboration with Newomics Inc. on a LC-MS platform for drug discovery. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。